GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases
CAMBRIDGE, Mass. – August 10, 2017– GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to large and diverse data sets to better match drugs and other health interventions to individual patients, today announced that it has entered into a license arrangement with Alexion for the rights to operate its REFS™ […]
CNBC’s Squawk Box Calls on GNS CEO Colin Hill to Understand Use of Big Data in Employee Wellness
Prompted by a Wall Street Journalarticle, CNBC’s Squawk Box Invited GNS CEO Colin Hill to explain the value of big data and machine learning-enabled employee wellness programs and to address concerns about privacy. Watch the segment here.
Personalized Medicine Coalition Welcomes GNS Healthcare as a New Member
GNS Healthcare applies causal machine learning technology to predict which treatments will work for which patients, improving individual patient outcomes and the health of populations, while reducing costs. Visit the Personalized Medicine Coalition’s Website here